Clinical characteristics of idiopathic interstitial pneumonias with anti-Ro52/tripartite motif-containing 21 antibodies

by Fujino, Y., Hasegawa, T., Ishimoto, H., Kido, T., Mukae, H., Sakamoto, N., Satoh, M., Tahara, M., Tanaka, S., Yamasaki, K., Yatera, K., Yura, H.
Published 2022

Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma

by Albright, A., Ayers, M., Burtness, B., Cheng, J., Chow, L.Q.M, Cristescu, R., Eder, J.P, Gluck, I., Gupta, S., Haddad, R.I, Huang, L., Kang, H., Keam, B., Lunceford, J., Mehra, R., Mogg, R., Muro, K., Seiwert, T.Y, Tahara, M., Weiss, J.
Published 2022

Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor...

by Blumenschein, G., Jr, Colevas, A.D, Docampo, L.C.I, Even, C., Fayette, J., Ferris, R.L, Gillison, M.L, Guigay, J., Haddad, R., Harrington, K.J, Jayaprakash, V., Kasper, S., Kiyota, N., Li, L., Licitra, L., Lynch, M., Rordorf, T., Saba, N.F, Tahara, M., Vokes, E.E, Worden, F.
Published 2018